Articles published by NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 17, 2026
Via GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals Begins Selling U.S.-Made, Preservative-Free Ketamine Amid Long-Running Shortage
November 11, 2026
Via GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
October 15, 2026
Via GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
September 08, 2026
Via GlobeNewswire
Tickers
NRXP
Via GlobeNewswire
Tickers
NRXP
Via GlobeNewswire
Tickers
NRXP
Via GlobeNewswire
Tickers
NRXP
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

